Adenosine promotes GATA-2-regulated p53 gene transcription to induce HepG2 cell apoptosis

Cellular Physiology and Biochemistry

Volumn 28, Issue 4, 2011, Pages 761-770

  Yaguchi, Takahiro ^a   Nakano, Takashi ^a   Gotoh, Akinobu ^a   Nishizaki, Tomoyuki ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

Adenosine; Apoptosis; GATA 2; HepG2 cell; p53

Indexed keywords

ADENOSINE; CASPASE 3; CASPASE 8; CASPASE 9; LUCIFERASE; MESSENGER RNA; PROTEIN P53; TRANSCRIPTION FACTOR GATA 2;

APOPTOSIS; ARTICLE; BINDING SITE; CELL STRAIN HEPG2; CELL VIABILITY; CONTROLLED STUDY; DNA PROBE; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE DELETION; GENE SILENCING; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN STRUCTURE; PROTEIN TARGETING; TRANSCRIPTION REGULATION;

EID: 83755225886     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000335770     Document Type: Article

References (33)

1. Saitoh M, Nagai K, Nakagawa K, Yamamura T, Yamamoto S, Nishizaki T: Adenosine induces apoptosis in the human gastric cancer cells via an intrinsic pathway relevant to activation of AMPactivated protein kinase. Biochem Pharmacol 2004;67:2005-2011. (Pubitemid 38591388)
2. Yasuda Y, Saito M, Yamamura T, Yaguchi T, Nishizaki T: Extracellular adenosine induces apoptosis in Caco-2 human colonic cancer cells by activating caspase-9/-3 via A2a adenosine receptors. J Gastroenterol 2009;44:56-65.
3. Sai K, Yang D, Yamamoto H, Yamamoto H, Fujikawa H, Yamamoto S, Nagata T, Saito M, Yamamura T, Nishizaki T: A1 adenosine receptor signal and AMPK involving caspase-9/-3 activation are responsible for adenosine-induced RCR-1 astrocytoma cell death. Neurotoxicol 2006;27:458-467. (Pubitemid 43867776)
4. Bar-Yehuda S, Stemmer SM, Madi L, Castel D, Ochaion A, Cohen S, Barer F, Zabutti A, Perez-Liz G, Del Valle L, Fishman P: The A3 adenosine receptor agonist CF102 induces apoptosis of hepatocellular carcinoma via deregulation of the Wnt and NF-B signal transduction pathways. Int J Oncol 2008;33:287-295.
5. Yang D, Yaguchi T, Yamamoto H, Nishizaki T: Intracellularly transported adenosine induces apoptosis in HuH-7 human hepatoma cells by downregulating c-FLIP expression causing caspase-3/-8 activation. Biochem Pharmacol 2007;73:1665-1675. (Pubitemid 46527539)
6. Yang D, Yaguchi T, Nakano T, Nishizaki T: Adenosine-induced caspase-3 activation by tuning Bcl-XL/DIABLO/ IAP expression in HuH-7 human hepatoma cells. Cell Biol Toxicol 2010;26:319-330.
7. Yang D, Yaguchi T, Lim C-R, Ishizawa Y, Nakano T, Nishizaki T: Tuning of apoptosis-mediator gene transcription in HepG2 human hepatoma cells through an adenosine signal. Cancer Lett 2010;29:225-229.
8. Earnshaw WC, Martins LM, Kaufmann SH: Mammalian caspases: structure, activation, substrates, and functions during apoptosis. Annu Rev Biochem 1999;68:383-424. (Pubitemid 29449198)
9. Micheau O, Tschopp J: Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 2003;114:181-190. (Pubitemid 36936912)
10. Schuler M, Green DR. Mechanisms of 53-dependent apoptosis. Biochem Soc Trans 2001 29 684-688. (Pubitemid 33131760)
11. Yee KS, Vousden KH: Complicating the complexity of p53. Carcinogenesis 2005;26:1317-1322. (Pubitemid 41430092)
12. Ploner C, Kofler R, Villunger A: Noxa: at the tip of the balance between life and death. Oncogene 2008;27:S84-92.
13. Yee KS, Vousden KH: Contribution of membrane localization to the apoptotic activity of PUMA. Apoptosis 2008;13:87-95.
14. Galluzzi L, Morselli E, Kepp O, Tajeddine N, Kroemer G: Targeting p53 to mitochondria for cancer therapy. Cell Cycle 2008;7:1949-1955. (Pubitemid 352030339)
15. Moll UM, Wolff S, Speidel D, Deppert W: Transcription-independent proapoptotic functions of p53. Curr Opin Cell Biol 2005;17:631-636.
16. Schuler M, Green DR: Mechanisms of p53-dependent apoptosis. Biochem Soc Trans 2001;29:684-688. (Pubitemid 33131760)
17. Speidel D: Transcription-independent p53 apoptosis: an alternative route to death. Trends Cell Biol 2010;20:14-24.
18. Kaneko H, Shimizu R, Yamamoto M: GATA factor switching during erythroid differentiation. Curr Opin Hematol 2010;17:163-168.
19. Bresnick EH, Lee HY, Fujiwara T, Johnson KD, Keles S: GATA switches as developmental drivers. J Biol Chem 2010;285:31087-31093.
20. Hosoya T, Maillard I, Engel JD: From the cradle to the grave: activities of GATA-3 throughout T-cell development and differentiation. Immunol Rev 2010;238:110-125.
21. Chou J, Provot S, Werb Z: GATA3 in development and cancer differentiation: cells GATA have it! J Cell Physiol 2010;222:42-49.
22. Trainor CD, Mas C, Archambault P, Di Lello P, Omichinski JG: GATA-1 associates with and inhibits p53. Blood 2009;114:165-173.
23. Tsai FY, Orkin SH: Transcription factor GATA-2 is required for proliferation/ survival of early hematopoietic cells and mast cell formation, but not for erythroid and myeloid terminal differentiation. Blood 1997;89:3636-3643. (Pubitemid 27227086)
24. Osamura RY, Egashira N, Kajiya H, Takei M, Tobita M, Miyakoshi T, Inomoto C, Takekoshi S, Teramoto A: Pathology, pathogenesis and therapy of growth hormone (GH)-producing pituitary adenomas: technical advances in histochemistry and their contribution. Acta Histochem Cytochem 2009;42:95-104.
25. Ozawa Y, Towatari M, Tsuzuki S, Hayakawa F, Maeda T, Miyata Y, Tanimoto M, Saito H: Histone deacetylase 3 associates with and represses the transcription factor GATA-2. Blood 2001;98:2116-2123.
26. Tsuzuki S, Enver T: Interactions of GATA-2 with the promyelocytic leukemia zinc finger (PLZF) protein, its homologue FAZF, and the t(11;17)-generated PLZF-retinoic acid receptor oncoprotein. Blood 2002;99:3404-410. (Pubitemid 34525323)
27. Herberth B, Minkó K, Csillag A, Jaffredo T, Madarász E: SCL, GATA-2 and Lmo2 expression in neurogenesis. Int J Dev Neurosci 2005;23:449-463. (Pubitemid 40981870)
28. Tsuzuki S, Towatari M, Saito H, Enver T: Potentiation of GATA-2 activity through interactions with the promyelocytic leukemia protein (PML) and the t(15;17)-generated PMLretinoic acid receptor alpha oncoprotein. Mol Cell Biol 2000;20:6276-6286. (Pubitemid 30650214)
29. Zhang P, Behre G, Pan J, Iwama A, Wara-Aswapati N, Radomska HS, Auron PE, Tenen DG, Sun Z: Negative cross-talk between hematopoietic regulators: GATA proteins repress PU.1. Proc Natl Acad Sci USA 1999;96:8705-8710. (Pubitemid 29354855)
30. Meulmeester E, Pereg Y, Shiloh Y, Jochemsen AG: ATM-mediated phosphorylations inhibit Mdmx/Mdm2 stabilization by HAUSP in favor of p53 activation. Cell Cycle 2005;4:1166-1170. (Pubitemid 41365384)
31. Cho YJ, Liang P: S-phase-coupled apoptosis in tumor suppression. Cell Mol Life Sci 2011;68:1883-1896.
32. Jung YS, Qian Y, Chen X: Examination of the expanding pathways for the regulation of p21 expression and activity. Cell Signal 2010;22:1003-1012.
33. Nakamura Y: Isolation of p53-target genes and their functional analysis. Cancer Sci 2004;95:7-11. (Pubitemid 38208400)